GENEVA – Switzerland on Saturday approved the use of the Pfizer-BioNTech vaccine, with immunization set to start just after Christmas as the country battles rising coronavirus cases.
The Swissmedic regulatory authority said it had given the green light following a two-month rolling review.
After a meticulous review of the available information, Swissmedic concluded that the COVID-19 vaccine from Pfizer-BioNTech is “safe and that its benefit outweighs the risks,” Swissmedic said. (AFP)
